CAREONE Allergy Relief 180 mg Tablets Recalled for Failed Impurities Specifications
Perrigo Company PLC is recalling CAREONE Allergy Relief (Fexofenadine HCL) 180 mg tablets nationwide because stability testing found impurity A out of specification.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illness or injury. The hazard is chemical degradation/impurity formation detected during stability testing, a quality control issue with theoretical rather than documented harm, placing this in the Moderate category per the rubric.
Plain-English summary
Perrigo Company PLC is recalling CAREONE Allergy Relief, Fexofenadine Hydrochloride Tablets 180 mg, an over-the-counter antihistamine. The recall affects 28,776 containers distributed nationwide in the USA.
The FDA Class II recall was issued because stability testing results showed impurity A levels that exceeded specification limits. This indicates degradation of the active ingredient or formation of unwanted compounds during the product's shelf life.
Affected products are sold in 30-count bottles (NDC 41520-229-39) and 45-count bottles (NDC 41520-229-95). Specific affected lot numbers and expiration dates are: Lot 0FR0459 (Exp 2/28/2022), Lot 0LR0362 (Exp 6/30/2022), Lot 1BR0462 (Exp 10/31/2022), and Lot 0LR0363 (Exp 6/30/2022). The product was made in the Czech Republic and distributed by Foodhold U.S.A. LLC of Landover, MD.
Consumers who have purchased affected CAREONE Allergy Relief should stop use and dispose of the product or return it to the place of purchase.
The recalled product
- Product
- CAREONE ALLERGY RELIEF (FEXOFENADINE HCL)
- Brand
- CAREONE ALLERGY RELIEF
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — OTC Antihistamine
- Hazard
- degradation
- out-of-specification-impurity
- stability-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot a) 0FR0459
- Exp 2/28/2022
- 0LR0362
- Exp 6/30/2022
- 1BR0462
- Exp 10/31/2022 b) 0LR0363
UPCs (2)
- 341520319846
- 341520319839
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CAREONE ALLERGY RELIEF
- HighCareone Allergy Relief tablets recalled for failed impurity and degradation specifications
FDA (Drugs) · 2023-07-19
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27